---
title: "GORDON KATHERINE — Ownership Dossier"
canonical: https://whiteintel.dev/entity/3f2511f3-3beb-5cc0-91cc-e993fc29a8bc
json: https://whiteintel.dev/api/public/dossier/3f2511f3-3beb-5cc0-91cc-e993fc29a8bc
identifier: sec:0001156392
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GORDON KATHERINE

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001156392`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/3f2511f3-3beb-5cc0-91cc-e993fc29a8bc  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/3f2511f3-3beb-5cc0-91cc-e993fc29a8bc  

## Ownership & control

### Holdings / subsidiaries

- **Lineage Cell Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/3d0dce36-5722-5eb1-b928-ce69417f4b69

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GORDON KATHERINE**. Human view: https://whiteintel.dev/entity/3f2511f3-3beb-5cc0-91cc-e993fc29a8bc · Structured JSON: https://whiteintel.dev/api/public/dossier/3f2511f3-3beb-5cc0-91cc-e993fc29a8bc._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._